Eikon Therapeutics

formerly EikonIPO

Bringing breakthrough therapeutics to patients with serious illnesses

Public · Hayward, United States · Founded 2019 · $1.1B raised

Employees
201–500
Founded
2019
Business Model
B2B
Total Funding
$1.1B
Last Round
$350.7M Series DFeb 2025
Rounds
4
Type
Public

About

Eikon Therapeutics is a clinical-stage biopharmaceutical company that has built the world's first high-throughput single-molecule tracking (htSMT) platform, enabling visualization of hundreds of thousands of protein motion events in living cells in under a second. Founded on Nobel Prize-winning super-resolution microscopy by Eric Betzig, Eikon uses this platform to discover and develop breakthrough oncology and neurological therapeutics. The company completed an IPO in early 2026, raising $381 million.

Summary

Eikon Therapeutics is an Artificial Intelligence company based in Hayward, United States, founded in 2019. It has raised $1.1B in total across 4 rounds, most recently a $350.7M Series D round in Feb 2025. Investors include T. Rowe Price, Andreessen Horowitz and Lux Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOFeb 2026
$381.0M

Sign up to see all 5 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eikon Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/eikon-therapeutics"><img src="https://indexed.vc/api/badge/company/eikon-therapeutics" alt="Eikon Therapeutics on Indexed.vc" width="260" height="76" /></a>